Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2008.06.010PMID 18640474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness in health and medicine

  2016cited by this paper
• Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.

  2007cited by this paper
• The Impact of Nebulized Levalbuterol on Health Care Payments for Elderly Asthma and Chronic Obstructive Pulmonary Disease Patients in Medicaid Plans

  2007cited by this paper
• Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma.

  2007cited by this paper
• Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

  2006cited by this paper
• Levosalbutamol in the treatment of asthma

  2006cited by this paper
• A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.

  2006cited by this paper
• Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.

  2005cited by this paper
• Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.

  2005cited by this paper
• Levalbuterol Versus Racemic Albuterol in the Treatment of Acute Exacerbation of Asthma in Children

  2005cited by this paper
• Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial.

  2005cited by this paper
• BREAKTHROUGH TREATMENTS RATES DURING A CONVERSION TO LEVALBUTEROL, TIOTROPIUM AND BREATH ACTUATED NEBULIZERS

  2005cited by this paper
• ECONOMIC IMPACT RESULTING FROM A CONVERSION TO LEVALBUTEROL EVERY SIX TO EIGHT HOURS

  2005cited by this paper
• (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells.

  2004cited by this paper
• Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.

  2004cited by this paper
• Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.

  2003cited by this paper
• Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation

  2003cited by this paper
• Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.

  2003cited by this paper
• Effect of Inhaled Racemic and (R)-Albuterol on Airway Vascular Smooth Muscle Tone in Healthy and Asthmatic Subjects

  2003cited by this paper
• Chronic obstructive pulmonary disease.

  2002cited by this paper
• Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.

  2002cited by this paper
• National Asthma Education and Prevention Program.

  2002cited by this paper
• The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.

  2001cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

  2001cited by this paper
• (S)-Albuterol Increases the Production of Histamine and IL-4 in Mast Cells

  2001cited by this paper
• World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects Revised October 7, 2000

  2001cited by this paper
• Asthma from the perspective of the patient.

  1999cited by this paper
• The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.

  1999cited by this paper
• Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.

  1998cited by this paper
• Pharmacokinetic and Pharmacodynamic Characteristics and Safety of Inhaled Albuterol Enantiomers in Healthy Volunteers

  1998cited by this paper
• Comparison of R-, S-, and RS-albuterol interaction with human beta 1- and beta 2-adrenergic receptors.

  1996cited by this paper
• Comparison ofR-, S-, andRS-albuterol interaction with human β1 and β2-adrenergic receptors

  1996cited by this paper
• Banks ALBUTEROL AND EFFICACY IN COMPARISON WITH PLACEBO AND RACEMIC LOW-DOSE LEVALBUTEROL IN CHILDREN WITH ASTHMA : SAFETY Services

  year unknowncited by this paper

• Chiral macrocyclic membranes for efficient enantioselective separation

  2025cites this paper
• Quantifying the Length of Stay and Economic Impact of Albuterol and Levalbuterol in Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study

  2024influential citation
• Safety outcomes of salbutamol: A systematic review and meta‐analysis

  2023influential citation
• How to Create a Primary Respiratory Care Model.

  2023cites this paper
• Levalbuterol vs. albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis

  2022cites this paper
• Fisher Digital

  2022cites this paper
• Medication Safety in Chronic Lung Disease with Cardiac Comorbidity

  2020cites this paper
• Acute exacerbation of chronic obstructive pulmonary disease Straight to the point of care

  2020cites this paper
• Asthma and COPD

  2020cites this paper
• Cardiac Considerations in Chronic Lung Disease

  2020cites this paper
• Awareness and Current Therapeutics of Asthma

  2019cites this paper
• Asthma Over the Age of 65: All's Well That Ends Well.

  2018cites this paper
• 44 – COPD: Clinical Diagnosis and Management

  2016cites this paper
• Ethnic differences in adverse drug reactions to asthma medications: a systematic review

  2016cites this paper
• Comparative Effectiveness Research and Cost-Consequence Analysis of Albuterol and Levalbuterol in Patients with Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Aérosols de médicaments

  2015cites this paper
• COPD: Optimizing treatment.

  2015cites this paper
• Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.

  2015cites this paper
• Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.

  2013cites this paper
• Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation

  2012cites this paper
• Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.

  2012cites this paper
• Tratamento farmacológico da DPOC* Pharmacological treatment of COPD

  2011cites this paper
• Pharmacological treatment of COPD.

  2011cites this paper
• Pharmacological treatment of COPD.

  2011influential citation
• Chronic Bronchitis and Emphysema

  2010cites this paper
• Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

  2010cites this paper
• Do inhaled levalbuterol and racemic albuterol have different cardiac effects

  2010cites this paper
• Management of COPD exacerbations.

  2010cites this paper
• Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD

  2010cites this paper
• Levalbuterol versus albuterol

  2009cites this paper
• Prescribing trends with levalbuterol (xopenex) at a community hospital.

  2009cites this paper
• Aérosols de médicaments

  2008cites this paper
• Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2007cites this paper